Filing Details
- Accession Number:
- 0001181431-10-002948
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-13 12:00:00
- Reporting Period:
- 2010-01-11
- Filing Date:
- 2010-01-13
- Accepted Time:
- 2010-01-13 16:57:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1174940 | Oragenics Inc | ORNI | Pharmaceutical Preparations (2834) | 593410522 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234877 | Beverly Koski | 1500 West University Parkway Sarasota FL 34243 | No | No | Yes | No | |
1234878 | L Christine Koski | 1500 West University Parkway Sarasota FL 34243 | Yes | No | Yes | No | |
1234879 | Koski Family Lp | 1500 West University Parkway Sarasota FL 34243 | No | No | Yes | No | |
1234880 | C Robert Koski | 1500 West University Parkway Sarasota FL 34243 | Yes | No | Yes | No | |
1234881 | L Thomas Koski | 1500 West University Parkway Sarasota FL 34243 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-11 | 200,000 | $0.25 | 54,160,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2010-01-12 | 200,000 | $0.25 | 54,360,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2010-01-13 | 600,000 | $0.25 | 54,960,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Shares acquired from the issuer on January 11, 12, and 13, 2010 in connection with the Company finalizing the December 30, 2009 $3.0 million private placement of restricted common stock.
- Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc.), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.